vs

Side-by-side financial comparison of Marathon Bancorp, Inc. (MBBC) and InspireMD, Inc. (NSPR). Click either name above to swap in a different company.

InspireMD, Inc. is the larger business by last-quarter revenue ($3.1M vs $2.2M, roughly 1.4× Marathon Bancorp, Inc.). On growth, InspireMD, Inc. posted the faster year-over-year revenue change (61.6% vs 41.7%). Marathon Bancorp, Inc. produced more free cash flow last quarter ($1.4M vs $-9.7M). Over the past eight quarters, InspireMD, Inc.'s revenue compounded faster (44.4% CAGR vs 20.3%).

Marathon Bancorp, Inc. is a Maryland-based financial holding company that primarily operates through its community bank subsidiary. It offers a full range of retail and commercial banking products including deposit accounts, consumer loans, commercial mortgages, and small business financing, serving individual and small-to-medium enterprise customers across local markets in Maryland.

InspireMD Inc. is a global medical device company specializing in innovative interventional cardiology and neurovascular solutions. Its flagship MGuard embolic protection stent line is engineered to reduce complications during vascular procedures, serving clinical customers across North America, Europe, and key Asia-Pacific markets, with a core focus on improving patient outcomes for acute coronary syndrome and stroke care.

MBBC vs NSPR — Head-to-Head

Bigger by revenue
NSPR
NSPR
1.4× larger
NSPR
$3.1M
$2.2M
MBBC
Growing faster (revenue YoY)
NSPR
NSPR
+19.9% gap
NSPR
61.6%
41.7%
MBBC
More free cash flow
MBBC
MBBC
$11.1M more FCF
MBBC
$1.4M
$-9.7M
NSPR
Faster 2-yr revenue CAGR
NSPR
NSPR
Annualised
NSPR
44.4%
20.3%
MBBC

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
MBBC
MBBC
NSPR
NSPR
Revenue
$2.2M
$3.1M
Net Profit
$501.4K
Gross Margin
37.5%
Operating Margin
26.2%
-383.7%
Net Margin
22.3%
Revenue YoY
41.7%
61.6%
Net Profit YoY
880.7%
EPS (diluted)
$0.19
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MBBC
MBBC
NSPR
NSPR
Q4 25
$2.2M
$3.1M
Q3 25
$2.1M
$2.5M
Q2 25
$1.9M
$1.8M
Q1 25
$1.7M
$1.5M
Q4 24
$1.6M
$1.9M
Q3 24
$1.6M
$1.8M
Q2 24
$1.6M
$1.7M
Q1 24
$1.6M
$1.5M
Net Profit
MBBC
MBBC
NSPR
NSPR
Q4 25
$501.4K
Q3 25
$444.3K
$-12.7M
Q2 25
$-332.0K
$-13.2M
Q1 25
$148.4K
$-11.2M
Q4 24
$51.1K
Q3 24
$174.9K
$-7.9M
Q2 24
$85.8K
$-7.9M
Q1 24
$-631.1K
$-7.0M
Gross Margin
MBBC
MBBC
NSPR
NSPR
Q4 25
37.5%
Q3 25
34.2%
Q2 25
17.6%
Q1 25
19.1%
Q4 24
24.1%
Q3 24
22.9%
Q2 24
19.0%
Q1 24
19.3%
Operating Margin
MBBC
MBBC
NSPR
NSPR
Q4 25
26.2%
-383.7%
Q3 25
25.5%
-517.3%
Q2 25
-25.7%
-732.2%
Q1 25
11.6%
-749.5%
Q4 24
3.3%
-480.6%
Q3 24
13.4%
-467.5%
Q2 24
4.1%
-475.0%
Q1 24
-53.7%
-490.7%
Net Margin
MBBC
MBBC
NSPR
NSPR
Q4 25
22.3%
Q3 25
20.7%
-503.7%
Q2 25
-18.9%
-739.7%
Q1 25
8.9%
-730.3%
Q4 24
3.2%
Q3 24
10.8%
-435.9%
Q2 24
6.2%
-454.8%
Q1 24
-40.7%
-465.4%
EPS (diluted)
MBBC
MBBC
NSPR
NSPR
Q4 25
$0.19
$-0.11
Q3 25
$0.17
$-0.17
Q2 25
$-0.13
$-0.26
Q1 25
$0.07
$-0.22
Q4 24
$0.02
$-0.17
Q3 24
$0.06
$-0.16
Q2 24
$0.07
$-0.22
Q1 24
$-0.31
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MBBC
MBBC
NSPR
NSPR
Cash + ST InvestmentsLiquidity on hand
$54.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$46.9M
$55.2M
Total Assets
$248.0M
$69.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MBBC
MBBC
NSPR
NSPR
Q4 25
$54.2M
Q3 25
$63.4M
Q2 25
$19.4M
Q1 25
$26.1M
Q4 24
$34.6M
Q3 24
$40.4M
Q2 24
$47.2M
Q1 24
$34.0M
Stockholders' Equity
MBBC
MBBC
NSPR
NSPR
Q4 25
$46.9M
$55.2M
Q3 25
$46.3M
$64.1M
Q2 25
$45.7M
$20.2M
Q1 25
$32.0M
$28.3M
Q4 24
$31.7M
$36.1M
Q3 24
$31.6M
$41.4M
Q2 24
$31.3M
$46.8M
Q1 24
$31.4M
$35.1M
Total Assets
MBBC
MBBC
NSPR
NSPR
Q4 25
$248.0M
$69.4M
Q3 25
$246.0M
$78.5M
Q2 25
$238.8M
$33.3M
Q1 25
$236.8M
$38.7M
Q4 24
$217.9M
$46.8M
Q3 24
$216.5M
$50.5M
Q2 24
$219.3M
$55.7M
Q1 24
$225.8M
$42.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MBBC
MBBC
NSPR
NSPR
Operating Cash FlowLast quarter
$1.4M
$-9.3M
Free Cash FlowOCF − Capex
$1.4M
$-9.7M
FCF MarginFCF / Revenue
62.3%
-309.4%
Capex IntensityCapex / Revenue
0.6%
12.6%
Cash ConversionOCF / Net Profit
2.82×
TTM Free Cash FlowTrailing 4 quarters
$3.9M
$-36.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MBBC
MBBC
NSPR
NSPR
Q4 25
$1.4M
$-9.3M
Q3 25
$464.0K
$-8.6M
Q2 25
$1.4M
$-8.3M
Q1 25
$849.0K
$-8.8M
Q4 24
$113.6K
$-6.8M
Q3 24
$945.2K
$-5.7M
Q2 24
$416.6K
$-4.4M
Q1 24
$-802.1K
$-5.1M
Free Cash Flow
MBBC
MBBC
NSPR
NSPR
Q4 25
$1.4M
$-9.7M
Q3 25
$456.6K
$-9.0M
Q2 25
$1.3M
$-8.9M
Q1 25
$773.2K
$-9.2M
Q4 24
$105.0K
$-7.1M
Q3 24
$921.6K
$-6.1M
Q2 24
$-1.8M
$-4.8M
Q1 24
$-1.1M
$-5.3M
FCF Margin
MBBC
MBBC
NSPR
NSPR
Q4 25
62.3%
-309.4%
Q3 25
21.3%
-355.2%
Q2 25
66.0%
-501.1%
Q1 25
46.3%
-598.5%
Q4 24
6.6%
-362.3%
Q3 24
57.1%
-338.2%
Q2 24
-118.5%
-277.7%
Q1 24
-67.9%
-348.0%
Capex Intensity
MBBC
MBBC
NSPR
NSPR
Q4 25
0.6%
12.6%
Q3 25
0.3%
13.0%
Q2 25
9.3%
32.4%
Q1 25
4.5%
23.5%
Q4 24
0.5%
16.0%
Q3 24
1.5%
23.3%
Q2 24
145.2%
27.3%
Q1 24
16.2%
12.9%
Cash Conversion
MBBC
MBBC
NSPR
NSPR
Q4 25
2.82×
Q3 25
1.04×
Q2 25
Q1 25
5.72×
Q4 24
2.22×
Q3 24
5.40×
Q2 24
4.85×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MBBC
MBBC

Segment breakdown not available.

NSPR
NSPR

Other$1.7M55%
US$1.4M45%

Related Comparisons